The company is an ophthalmology medical group with the scale of hospitals and high-quality medical capabilities in China and around the world. It is committed to introducing and absorbing internationally synchronized ophthalmology technology and medical management concepts, using specialization, scale and science as a development strategy to promote the development of ophthalmology in China. As a professional ophthalmology chain medical institution, the company is mainly engaged in diagnosis and treatment of various ophthalmic diseases, surgical services, and medical optometry equipment. Currently, the medical network covers mainland China, Hong Kong, Europe, the United States, and Southeast Asia, establishing a strategic pattern for global development. Corporate honors: Aier Ophthalmology also won the top ten “Listed Companies Most Respected by Investors” in China, Aier Ophthalmology won the Best Sustainable Investment Value Award, the Most Influential Listed Company Leader Award, Gold Medal, Aier Ophthalmology won the 2017 China Listed Company Best Shareholder Return Award, Aier Ophthalmology was listed among the top 500 Chinese and world brands, and Aier Ophthalmology won the 2021 “China Red Cross Contribution Medal”.